Form 4 for BSX Boston Scientific
Accepted 2023-02-06 00:00:00 ET · period of report 2023-02-03 · accession 0001225208-23-001356 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-06 | 2023-02-03 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | M - OptEx | $16.58 | +15.0K | 50.4K | +43% | +$249.2K |
| D | 2023-02-06 | 2023-02-03 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | S - Sale+OE | $48.74 | -27.0K | 23.4K | -54% | -$1.32M |
| DM | 2023-02-06 | 2023-02-03 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | M - OptEx | $0.00 | -15.0K | 11.9K | -56% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-03 | M | A | 10,822 | $16.31 | 46,180 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-03 | M | A | 4,212 | $17.26 | 50,392 | D | — | — | |
| 3 | Common | Common Stock | 2023-02-03 | S | D | 27,000 | $48.74 | 23,392 | D | — | — | (F1) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $48.70 to $48.78, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Derivative | Stock Option (Right to Buy) | 2023-02-03 | M | D | 10,822 | $0.00 | 0 | D | $16.31 · — to 2025-02-23 | 10,822 Common Stock | (F4) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant. |
| 5 | Derivative | Stock Option (Right to Buy) | 2023-02-03 | M | D | 4,212 | $0.00 | 11,931 | D | $17.26 · — to 2026-02-22 | 4,212 Common Stock | (F3) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. |